Athira Pharma Stock Insider Trading

Healthcare > Biotechnology

Buy ATHA

*Your capital is at risk

$6.61

+0 (+0%)

At Close: Apr 14, 2026

Athira Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 97.91. In total, the insiders bought 22.45M and sold 118.11K ATHA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	97.91
● Buy	22.45M shares
● Sell	118.11K shares
85% Buy Activity Weak Positive Correlation
Buy Signal High Confidence Dec 23, 2025 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 97.91. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (85% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 02, 2026 Sell	Common Stock S-Sale	Worthington Mark General Counsel And Cco	Officer	876 Value: $6K
Jan 02, 2026 Sell	Common Stock S-Sale	Church Kevin Chief Scientific Officer	Officer	876 Value: $6K
Jan 02, 2026 Sell	Common Stock S-Sale	Renninger Robert Chief Financial Officer	C-Suite Officer	297 Value: $2K
Jan 02, 2026 Sell	Common Stock S-Sale	Litton Mark James President And CEO	CEO / President	2 586 Value: $17.8K
Jan 02, 2026 Sell	Common Stock S-Sale	San Martin Javier Chief Medical Officer	Officer	1 644 Value: $11.3K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Worthington Mark General Counsel And Cco	Officer	3 667 Value: $27.8K
Dec 31, 2025 Buy	Common Stock M-Exempt	Worthington Mark General Counsel And Cco	Officer	3 667 Value: $27.8K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Church Kevin Chief Scientific Officer	Officer	3 667 Value: $27.8K
Dec 31, 2025 Buy	Common Stock M-Exempt	Church Kevin Chief Scientific Officer	Officer	3 667 Value: $27.8K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Renninger Robert Chief Financial Officer	C-Suite Officer	1 236 Value: $9K
Dec 31, 2025 Buy	Common Stock M-Exempt	Renninger Robert Chief Financial Officer	C-Suite Officer	1 236 Value: $9K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	Litton Mark James President And CEO	CEO / President	10 834 Value: $82.0K
Dec 31, 2025 Buy	Common Stock M-Exempt	Litton Mark James President And CEO	CEO / President	10 834 Value: $82.0K
Dec 31, 2025 Buy	Restricted Stock Units M-Exempt	San Martin Javier Chief Medical Officer	Officer	4 667 Value: $35.3K
Dec 31, 2025 Buy	Common Stock M-Exempt	San Martin Javier Chief Medical Officer	Officer	4 667 Value: $35.3K
Dec 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Worthington Mark General Counsel And Cco	Officer	34 358 Value: $139.8K
Dec 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Renninger Robert Chief Financial Officer	C-Suite Officer	34 358 Value: $139.8K
Dec 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Litton Mark James President And CEO	CEO / President	133 526 Value: $508.7K
Dec 24, 2025 Buy	Stock Option (Right to Buy) A-Award	Church Kevin Chief Scientific Officer	Officer	35 138 Value: $143.0K
Dec 24, 2025 Buy	Stock Option (Right to Buy) A-Award	San Martin Javier Chief Medical Officer	Officer	44 508 Value: $181.1K
Dec 23, 2025 Buy	Series B Warrant (right to buy) A-Award	Perceptive Advisors Llc	Director	1 181 101 Value: $9.00M
Dec 23, 2025 Buy	Pre-Funded Warrant (right to buy) A-Award	Perceptive Advisors Llc	Director	457 645 Value: $458
Dec 23, 2025 Buy	Common Stock A-Award	Perceptive Advisors Llc	Director	329 756 Value: $2.09M
Dec 23, 2025 Buy	Pre-Funded Warrant (right to buy) A-Award	Perceptive Advisors Llc	Director	5 502 402 Value: $6K
Dec 23, 2025 Buy	Series A Warrant (right to buy) A-Award	Perceptive Advisors Llc	Director	3 838 583 Value: $24.4M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks